find much like zoeti wide moat
updat forecast estim feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
zoeti clear leader global anim health industri
believ possess widest moat player
industri whole possess mani characterist
conduc moat zoeti global infrastructur give cost
advantag peer firm also fend competit
impress breadth product portfolio
includ number drug specif canin felin ailment
anim health industri larg ignor
busi often buri within larger human health compani
mani attract characterist includ cash-pay
buyer fragment custom base minim gener
competit due fragment cash-pay custom base
anim drugmak hold signific price power human
health side firm tradit merci payer
govern payer larg managed-car firm pharmaci
benefit manag power forc gener util
squash price increas even extrem case forc price cut
onto drug manufactur howev anim health product
purchas fragment group protein produc
veterinarian pet owner allow littl bargain
power highli concentr anim health firm
industri also benefit favor growth tailwind
allow zoeti increas revenu mid-single-digit
long-term growth rate product anim side rise
standard live emerg market lead wider
adopt meat-heavi diet drive greater demand livestock
product companion side zoeti benefit pet owner
increasingli strong relationship pet member
famili drastic increas willing pay
expens treatment zoeti like grow rate rel
close industri abl maintain
above-averag margin due scale especi emerg
market zoeti scale allow use salesforc
smaller competitor often forc reli expens
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zoeti sell anti-infect vaccin parasiticid diagnost
health product anim firm earn total revenu
product anim cattl pig poultri companion
anim dog hors cat product make remaind firm
largest market share industri previous anim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
boost fair valu estim per
share reflect slightli optimist project
companion anim growth next four year
improv profit longer term well cash
flow realiz sinc
low-double-digit annual growth companion anim
segment drive total
revenu growth period project
growth earn interest long term
ration
remain favor profit gain follow
product portfolio
invest brand companion anim drug busi
project adjust oper margin reach
basi point next five year
expect improv split nearli evenli
gain gross margin thank slim
product portfolio product anim consolid
manufactur site half driven
effici deploy sale field support howev
benefit firm effici program
slightli off-set lower-margin emerg market make
grow portion zoeti sale well greater
 invest maintain brand drug innov
whole project factor translat
adjust averag annual earn growth
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium
base case forecast long-term tax rate
long-term oper margin firm
abl boost sale product anim product
leverag greater price power companion anim
portfolio project adjust oper margin
fair valu estim would per share firm
lose revenu due greater restrict
antibiot use anim face flat oper margin
penetr emerg market pressur profit
fair valu would fall per share
zoeti enjoy wide econom moat thank intang
asset scale although patent essenti
maintain product anim health industri least
firm revenu come product protect
patent allow zoeti charg premium price
insul competit firm strong brand name
anoth advantag competitor custom
use drug potenti million dollar worth
livestock pet love like famili member
will pay premium buy firm trust
zoeti also enjoy anoth intang asset comparison
competitor embed larger human
pharmaceut firm zoeti free develop therapeut
base unmet anim need competitor applic
therapeut origin design human anim
market also mean firm unlik invest
animal-specif therapi sizabl opportun
relat unmet anim need zoeti pioneer
includ cytopoint canin allergi
scale also provid zoeti key advantag
highli fragment custom base salesforc
distribut relationship extrem import
launch new product simpl get one
larg payer managed-car organ medicar
govern board compani need individu
deal veterinarian meat produc zoeti broad
portfolio support salesforc allow firm
bypass distributor
barrier entri signific capit time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
although nearli expens time-consum
human health still challeng bring new
anim health product market given small market
size rel modest sale potenti product
reward often justifi new competitor pursu
clinic trial bring product market
believ zoeti stabl moat trend compani
compet matur industri experienc
signific chang even spin-out eli lilli
anim health unit elanco consid heavi
concentr among top firm revolutionari
product develop expect industri
face materi chang competit landscap
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ogrow interest probiot antibacteri peptid
immun modul altern antibiot
offer mani target innov
ostrict regul restrict antibiot use
ocompanion anim increasingli view famili
spend pet healthcar
olower-margin emerging-market sale make
increas portion compani sale creat
headwind zoeti margin
osinc anim health industri lack larg payer
like medicar single-pay govern larg
oemerging-market custom may price-
sensit open use gener product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
zoeti enjoy solid financi flexibl even leverag
tick financ purchas pharmaq
abbott anim health busi long-term debt
billion end zoeti alreadi brought
debt/ebitda time time three
year expect leverag land low end
target rang time end year
remain comfort interest coverag around time
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium thank grow consum
concern use antibiot food suppli
 food drug administr meat product
industri final begun react industri alreadi
roll new standard call voluntari monitor
use anim howev grassroot pressur continu
build risk fda could eventu issu
restrict guidelin product anim
segment offer rel steadi growth remain expos
macroeconom trend emerg market
adopt higher-protein diet like fuel
underli demand zoeti product slower growth
china brazil rippl effect could reach zoeti
companion anim market price elast pet health
care clear pet owner continu spend
pet point rise price may
owner will bear segment
market vulner macroeconom downturn
caus consum pull back spend
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
base nearli three year sinc zoeti spun
give firm standard stewardship rate
ceo juan ramon alaix previous ran busi
presid anim health busi firm
separ leadership anim health unit
success integr fort dodg anim health
alpharma acquisit region
presid central/southern europ
pharmaceut divis believ seven year run
compani give signific oper experi
thu far alaix focus increas zoeti scale
breadth seri acquisit allow
firm enter adjac market includ aquacultur
monoclon antibodi pet
abrupt departur former cfo paul herendeen
valeant current cfo glenn david prove
highli compet role david longtim
veteran deep experi healthcar
well acquisit integr new busi
expect see dramat departur
firm current strategi serial acquisit though leverag
settl lower expect
herendeen aggress stanc
repres date owner name posit common share held report holder issuer
fidel manag research compani
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
zoeti flex wide moat muscl chang
fve feb
zoeti report fourth-quart full-year perform
slightli outpac estim top line
off-set modestli higher manufactur sale
market expens make small adjust
model plan leav fair valu estim unchang
demonstr evid wide econom moat
robust pipelin featur new product offer novel
benefit think partial reflect
zoeti expertis manag product life cycl also
think firm done nice job take animal-
center approach innov weve discuss
anim health therapeut often
consid potenti applic human use
pharmaceut compani zoeti freedom
devot develop resourc animal-specif issu
product portfolio reflect orient
organ part
come fourth quarter saw oper
revenu growth basi point volum
price respect think zoeti remain good
posit meet expect particular
new fostera gold pcv mh vaccin swine see
revolut cat novel inject heartworm
protect deck launch year find
latter especi intrigu popular
heartworm prevent oral chewabl must
administ monthli vet mani part
countri recommend owner keep dog heartworm
prevent year-round think inject
last month could conveni option longer
length efficaci substanti improv zoeti
exist proheart vaccin last six month
one area soft like worsen
cattl beef dairi herd exit all-tim
demand seem soften could see market
weaken year base manag remark
zoeti expect headwind market
off-set strength swine poultri aquacultur
rule unconstitut district court
near-term impact fundament dec
dec judg reed connor northern district
texa issu rule effect declar patient
protect afford act
unconstitut assum littl chang
compani cover healthcar sector
near term rule like make way
appeal process surpris see
case third appear make front
 suprem court potenti timelin final
basi decis find root congress
elimin shared-respons financi penalti
accompani passag tax cut job act
late last year short judg connor found individu
mandat essenti insever provis
congress decis elimin enforc
tax penalti law render entireti
legisl unconstitut logic follow
 suprem court decis upheld
constitut congress power taxat
view healthcar provid sector at-risk
stem chang prevail healthcar
legisl whether chang individu coverag
roll-back medicaid expans higher uninsur
rate unequivoc equat pressur hospit margin
payer perspect trade-off littl less clear
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
although medicaid-focus insur like feel
bulk enrol loss
intend make chang moat rate fair
valu estim result decis continu
monitor case make way appel
court come month outcom timelin
uncertain make meaning chang
assumpt earli day addit wildcard
potenti legisl action muddi
ultim financi penalti carri
insur coverag set end jan
understand feder govern intend
maintain statu quo appeal process
insur alreadi lock rate propos
earliest like see potenti effect
rule premium polici offer slate
open enrol season
zoeti report strong third-quart perform held
surpris leav fair valu estim
unchang firm track meet full-year
project although cattl segment display
soft entir livestock divis saw healthi quarterli
oper growth thank double-digit growth
poultri fish typic companion anim
segment grew faster oper third
quarter includ addit abaxi diagnost
busi continu strength firm new product
addit invest manufactur capac
commerci organ underscor zoeti
zoeti abl reap reward invest
novel therapeut specif develop
companion anim market apoquel cytopoint
domin leader dermatolog market
estim share along simparica collect
novel product fuel double-digit growth zoeti
companion anim segment offset declin
older product manag reveal work
new monoclon antibodi pain dog cat
could big opportun arthriti older
companion anim quit common main treatment
option pet current non-steroid anti-
inflammatori may may effect
long term clear mechan action
character new therapi seen human
pharmaceut compani attempt address pain
monoclon antibodi target nerv growth factor
case therapi turn significantli
efficaci nsaid human entir class
drug dog troubl side effect
recent human side effect concern
acceler deterior affect arthrit joint
lead earlier greater incid joint replac
howev clear whether deterior due
actual therapeut agent simpli driven
aggress patient use joint pain reliev
class drug eventu approv human use
expect market potenti could substanti
howev consid number time regul
interven halt clinic trial due emerg
side effect less confid therapi
reach commerci human hand
lower hurdl anim use could work zoeti favor
expect monoclon antibodi pain reach canin
market human market
rise tariff meat leav us cautiou zoeti
livestock segment chang fve oct
hold steadi fair valu estim zoeti
per share make slight adjust
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
product anim project
product segment tend grow long term along
economi expect could addit
pressur trickl rise tariff attach
meat midterm enough
move needl valuat may make
revis zoeti report third-quart result week
zoeti seen sever quarter robust revenu growth
product anim segment strength swine
poultri thank increas meat product
occur feed price fallen expect see rise
tariff pork china mexico whop
tariff respect could damp demand
farmer slow expans worst begin cull
livestock especi feed price rise zoeti would also
see swine sale come pressur although swine
sale contribut zoeti total revenu
declin set could modestli hurt zoeti perform
midterm
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
